EXPERT SPEAKERS

Aarti Sharma

Associate Director

Regeneron Pharmaceuticals Inc

Akinori Hishiya

CSO

SOLA Biosciences

angela

Angela Genge

ALS Centre of Excellence

McGill University

Arti Patel

Principle Scientist II

Novartis AG

Bijan Nejadnik

Head of Global Development, Regulatory Affairs & Quality Assurance

Mitsubishi Tanabe Pharma

Christopher Ocampo

Senior Medical Director

Abbvie

Collin Hovinga

Vice President of Rare and Orphan Diseases

Critical Path Institute

Diego Cadavid

Chief Medical Officer

Verge Genomics

Disha Sood

Senior Scientist

Sanofi

Emily Caporello

Director, Small Business Program

NINDS/NIH

Emma Bowden

Vice President & Head of Clinical Development

QurAlis Corp.

Fen Huang

Director - Translational Sciences

Denali Therapeutics Inc.

Fred Grossman

President & Chief Medical Officer

Coya Therapeutics

Howard Rutman

Chief Medical Officer

Xalud Therapeutics

Karen King

Member

Genetic ALS & FTD: End the Legacy

Layne Oliff

ALS Advocate

I AM ALS

Laynie Dratch

Genetic Counselor

Penn Medicine

Mansuo Lu Shannon

Chief Scientific Officer

Prevail Therapeutics

Marjan Sepassi

Vice President - Medical Affairs

Clene Nanomedicine

Mary Kay Turner

Vice President - Global Patient Advocacy & Government Affairs

BrainStorm Cell Therapeutics

Neil Shneider

Director

The Eleanor and Lou Gehrig ALS Center, Columbia University

Neta Zach

Head of Neuroscience Experimental Medicine

Takeda Pharmaceutical Co. Ltd.

Paul Wicks

Advocate

Independent

Paul Wright

Head of Motor Neuron Disease Translational Challenge

LifeArc

Petra Duda

Head of Development

UCB Pharma

Philip Wong

Professor

Johns Hopkins University

Robert Bowser

Chief Scientific Officer

Barrow Neurological Institute

Sabrina Paganoni

Co-Director - Neurological Clinical Research Institute

Massachusetts General Hospital (MGH) and Harvard Medical School

Sakshi S

Senior Director

Critical Path Institute

Sarah Luppino

Nurse Practitioner & Healey & AMG Center for ALS Research Site Director

Massachusetts General Hospital (MGH) and Harvard Medical School

Sharon Tamir

Digital Healthcare Innovation, Business and Research Strategy

Mitsubishi Tanabe Pharma

Shih-Ching (Joyce) Lo

Associate Director

Biogen

Shiran Zimri

Vice President of Research and Development

NeuroSense Therapeutics

Sophie Parmentier Batteur

Head of Neurodegeneration

Novartis

Stacy Lindborg

co-Chief Executive Officer

BrainStorm Cell Therapeutics

Stephanie Fradette

VP, Head of Neuromuscular Development Unit

Biogen

T.D. Barbara Nguyen-Vu

Senior Director - Neuro

MeiraGTx

Tao Yang

Director - Computational Biology

Prevail Therapeutics

Wen-Hsuan Chang

Head of Target Validation

AcuraStem Inc.

Yuqiang Wang

Founder and CEO

Magpie Pharmaceuticals

FULL EVENT GUIDE
REGISTER